{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:36Z","timestamp":1793061336818,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018928","name":"Westlake University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102936","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:56:57Z","timestamp":1784818617000},"page":"102936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit"],"prefix":"10.1016","volume":"7","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102936_bib1","first-page":"12","article-title":"Cancer statistics, 2024. CA: A Cancer","volume":"74","author":"Siegel","year":"2024","journal-title":"J. Clin."},{"key":"10.1016\/j.xcrm.2026.102936_bib2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41587-019-0137-8","article-title":"Gene editing for immune cell therapies","volume":"37","author":"Bailey","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102936_bib3","first-page":"510","article-title":"Force platform measures for evaluating postural control: reliability and validity","volume":"70","author":"Goldie","year":"1989","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.xcrm.2026.102936_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605380","article-title":"Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters","volume":"10","author":"Monta\u00f1o-Samaniego","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102936_bib5","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.ymthe.2021.04.006","article-title":"Prodrugs and prodrug-activated systems in gene therapy","volume":"29","author":"Sheikh","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2018.04.003","article-title":"Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect","volume":"11","author":"Chen","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2026.102936_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975233","article-title":"Combinatorial suicide gene strategies for the safety of cell therapies","volume":"13","author":"Falcon","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102936_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2015.05.009","article-title":"Progress and problems with the use of suicide genes for targeted cancer therapy","volume":"99","author":"Karjoo","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.102936_bib9","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1038\/s41467-019-10912-8","article-title":"A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102936_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1078-0432.CCR-1075-3","article-title":"Telomerase-specific replication-selective virotherapy for human cancer","volume":"10","author":"Kawashima","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102936_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gt.3302385","article-title":"Evaluation of tumor-specific promoter activities in melanoma","volume":"12","author":"Lu","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/gt.2009.103","article-title":"A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses","volume":"16","author":"Rojas","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib13","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific Association of Human Telomerase Activity with Immortal Cells and Cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102936_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1147","article-title":"Clinical development of gene therapy for colorectal cancer","volume":"3","author":"Kerr","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrc2247","article-title":"Carboxypeptidase G2-based gene-directed enzyme\u2013prodrug therapy: a new weapon in the GDEPT armoury","volume":"7","author":"Hedley","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat1642","article-title":"An EVolving approach to directed enzyme prodrug therapy for cancer","volume":"10","author":"Jay","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102936_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41417-021-00331-7","article-title":"Vector engineering, strategies and targets in cancer gene therapy","volume":"29","author":"Singh","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib19","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188872","article-title":"ETS transcription factors: Multifaceted players from cancer progression to tumor immunity","volume":"1878","author":"Wang","year":"2023","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113069","article-title":"The interaction between ETS transcription factor family members and microRNAs: A novel approach to cancer therapy","volume":"150","author":"Du","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2026.102936_bib22","first-page":"1","article-title":"Understanding the role of ETS-mediated gene regulation in complex biological processes","volume":"119","author":"Findlay","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102936_bib23","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1038\/sj.onc.1204036","article-title":"Signal transduction and the Ets family of transcription factors","volume":"19","author":"Yordy","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.102936_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3109\/10409238.2013.838202","article-title":"Molecular mechanisms of ETS transcription factor-mediated tumorigenesis","volume":"48","author":"Kar","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102936_bib25","article-title":"Translocations involving ETS family proteins in human cancer. Integr","volume":"5","author":"Fry","year":"2018","journal-title":"Cancer Sci. Ther"},{"key":"10.1016\/j.xcrm.2026.102936_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrc.2017.20","article-title":"The ETS family of oncogenic transcription factors in solid tumours","volume":"17","author":"Sizemore","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"Russell","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.xcrm.2026.102936_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s43018-021-00250-4","article-title":"Moving pan-cancer studies from basic research toward the clinic","volume":"2","author":"Chen","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"Aaltonen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102936_bib30","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/cancers16091705","article-title":"Survivin as a Therapeutic Target for the Treatment of Human Cancer","volume":"16","author":"Wang","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2026.102936_bib31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrc4018","article-title":"Directly targeting transcriptional dysregulation in cancer","volume":"15","author":"Gonda","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/med.21575","article-title":"ETS transcription factors as emerging drug targets in cancer","volume":"40","author":"Hsing","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.xcrm.2026.102936_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102936_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV Serotypes 1\u20139 Mediated Gene Expression and Tropism in Mice After Systemic Injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib37","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102936_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102936_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.102936_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.102936_bib41","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.3390\/cancers14235820","article-title":"Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer","volume":"14","author":"Kushiya","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2026.102936_bib42","first-page":"362","article-title":"Survivin in lung cancer: a potential target for therapy and prevention\u2014a narrative review. Transl","volume":"13","author":"Pachimatla","year":"2024","journal-title":"Lung Cancer Res"},{"key":"10.1016\/j.xcrm.2026.102936_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib44","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","article-title":"Trends in the approval of cancer therapies by the FDA in the twenty-first century","volume":"22","author":"Scott","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102936_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the Path to Cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-\u03baB a good target for cancer therapy? Hopes and pitfalls","volume":"8","author":"Baud","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102936_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41587-021-01057-5","article-title":"Direct targeting of amplified gene loci for proapoptotic anticancer therapy","volume":"40","author":"Kaushik Tiwari","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102936_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303114120","article-title":"Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance","volume":"120","author":"Wan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102936_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102936_bib51","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102936_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102936_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao3048","article-title":"Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway","volume":"361","author":"Bugaj","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102936_bib54","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMsb1607705","article-title":"Limits to Personalized Cancer Medicine","volume":"375","author":"F","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102936_bib55","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/14712598.2021.1902982","article-title":"Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer","volume":"21","author":"Collins","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102936_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevOncog.2016016084","article-title":"Gene Therapy for Lung Cancer","volume":"21","author":"Lara-Guerra","year":"2016","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.xcrm.2026.102936_bib58","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1038\/s41467-019-12794-2","article-title":"Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102936_bib59","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1093\/nar\/gkq966","article-title":"High-level expression by tissue\/cancer-specific promoter with strict specificity using a single-adenoviral vector","volume":"39","author":"Kanegae","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102936_bib60","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.ymthe.2024.04.025","article-title":"Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition","volume":"32","author":"Lin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102936_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102936_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-7223-4_9","article-title":"Mammalian Synthetic Promoters","volume":"1651","author":"Lopez","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102936_bib64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/mt.2010.79","article-title":"Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth","volume":"18","author":"Guedan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102936_bib65","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102936_bib66","doi-asserted-by":"crossref","DOI":"10.3791\/61616","article-title":"Murine Excisional Wound Healing Model and Histological Morphometric Wound Analysis","author":"Rhea","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.xcrm.2026.102936_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102936_bib68","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.xcrm.2026.102936_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0303-7207(01)00674-8","article-title":"Insulin receptor tyrosine kinase activity and phosphorylation of tyrosines 1162 and 1163 are required for insulin-increased prolactin gene expression","volume":"186","author":"Jacob","year":"2002","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:25:55Z","timestamp":1793060755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003538"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102936","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102936"}}